chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shortness of breath, difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath, difficulty breathing) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN, CLONAZEPAM (KLONOPIN), PAROXETINE HYDROCHLORIDE (PAROXETIN +PHARMA) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced DYSPNOEA (shortness of breath, difficulty breathing). At the time of the report, DYSPNOEA (shortness of breath, difficulty breathing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MODERNATX, INC.-MOD-2021-092184 (E2B Linked Report); Sender's Comments:  MODERNATX, INC.-MOD-2021-092184:Dose1
Patient developed localized rash on 5/10/10 on right shoulder that spread to rest of her arm. Rash was itchy, but not painful. She developed > 500 maculopapular vesicular lesions. Physician diagnosed her with herpes zoster. Patient had no history of varicella or herpes zoster.
Initial report was received on 10 November 2011 from a consumer who received the report from the patient. A female patient (age not reported) had received an INFLUENZA VACCINE (manufacturer, lot number, route, site and date of administration not reported) and an unspecified amount of time after receiving the vaccine, experienced a stroke and was hospitalized for ten days (dates not reported). Treatments were not reported. No further information was available at the time of the report. Outcome was not reported. Documents held by sender: none.
I had extreme head pressure and pain. I went the the emergency room when I became incoherent and I was unable to understand what was happening, The head pain became so intense that an ambulance was called and I was taken to the hospital. I received IV medication for pain and was kept overnight for observation.
Localized induration over the Left shoulder deltoid muscle.  Patient also had very high grade fevers to 103 for 48 hours, but she has had serious prior episodes of fevers in the past.
rash; had an itch in the upper arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose number Unknown, Manufacturer unknown), for Covid-19 Immunization.  The following information was reported: RASH (non-serious), outcome "unknown", described as "rash"; PRURITUS (non-serious), outcome "unknown", described as "had an itch in the upper arm".  Additional information: Her friend had a booster shot and had an itch in the upper arm, also she had a rash 2 and a half weeks later after her booster shot, and wondered if anyone else had it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Nausea, vomiting, diarrhea for 5 days. One week later Covid arm-red,swollen, itchy painful.
headache that progressed to a migraine with vision disturbances lasting 12 hours.  Next day a feeling of a numb delicate head persisted for another 8 hours or so
severe sweating on his head; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (severe sweating on his head) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced HYPERHIDROSIS (severe sweating on his head). At the time of the report, HYPERHIDROSIS (severe sweating on his head) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information was reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Telephone Contact Report- Incorrect contact information.
received 0.5ml Moderna instead of 0.25ml booster dose/Incorrect Booster Dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (received 0.5ml Moderna instead of 0.25ml booster dose/Incorrect Booster Dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012h21b) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (received 0.5ml Moderna instead of 0.25ml booster dose/Incorrect Booster Dose). At the time of the report, ACCIDENTAL OVERDOSE (received 0.5ml Moderna instead of 0.25ml booster dose/Incorrect Booster Dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.
Fever; Dizzy; didn't feel right; little chills; Blood pressure was kind of low; This is a spontaneous report from a contactable consumer (the patient). An 83-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not provided), via an unspecified route of administration on 04Feb2021 around 14:30 or 14:45 (at the age of 83-years-old) as a single dose for COVID-19 immunization. The patient had no medical history or concomitant medications. The patient previously received the first dose of the COVID-19 vaccine on an unspecified date, 3 weeks before, for COVID-19 immunization. On 05Feb2021, the patient experienced fever, dizzy, didn't feel right. On an unspecified date in Feb2021, the patient experienced little chills and blood pressure was kind of low. The clinical course was as follows: The patient got her second COVID shot last Thursday 04Feb2021. She felt fine. Then, on Friday evening (05Feb2021), she started feeling bad. She had a fever and was dizzy, little chills and her blood pressure was kind of low. She had been trying to drink not today (as reported). Today was Monday (08Feb2021), and she still had a low fever. She still didn't feel right. She hasn't felt right since Friday and was improving a little. Her fever wasn't that bad now, but at night it was a little over 100. The clinical outcome of fever, dizzy, didn't feel right was recovering. The outcome of other events was unknown.  Information on the lot/batch number has been requested.
10/21/2006 pt developed low fever on 10/21, went up to 103, felt lousy.
2 days after getting vaccines PENTACEL, PREVNAR, ROTATEQ, the baby came to the office in distress, was resuscitated and sent to the hospital.
Localized swelling in face where I have hyaluronic acid dermal fillers (undereye/upper cheek). Began overnight after dose approximately 18 hours after vaccine administered.
January 12-13 felt slight flu symptoms and chills  January 14 redness, blotchy area at injection site. 4cm×4cm
On 11/3/21 the patient had emesis, followed by 2 loose bowel movements. Patient was started on Miralax.  The patient had decrease food and fluid intake.  Was given 2 L of IV fluids on 11/16/21.  Due to abnormal lab results the  patient was transferred to the hospital on 11/18/21.  The patient was transferred back from hospital with orders for hospice.
Exhaustion still 5 days later. Just been sleeping. Having hard time breathing, catching my breath. Have not gone to dr yet.
Patient feels like her entire body is heavy and tingling.  She is very dizzy.  She is having some mile check pain that she rates as a 1 out of 10.  She denies any fevers.  She is otherwise healthy.  BP 97/83 at 1014, 114/74 at 1030, HR 95 at 1014, 82 at 1030.  She got 1 L of NaCl and felt better, discharged home.
did not know she was pregnant at the time she got the vaccines.; miscarriage symptoms; vaginal bleeding; This prospective pregnancy case was reported by a nurse via call center representative and described the occurrence of threatened abortion in a 21-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA267A, expiry date 31st March 2021) for prophylaxis.   Co-suspect products included Men B NVS (Bexsero) (batch number ABXA14BA, expiry date 31st March 2021) for prophylaxis.   On 19th August 2020, the patient received Menveo and Bexsero. The patient's last menstrual period was on an unknown date and estimated date of delivery was on an unknown date. The patient received Menveo at an unknown time during the pregnancy. On 2nd September 2020, 14 days after receiving Menveo and Bexsero, the patient experienced threatened abortion (serious criteria GSK medically significant) and vaginal bleeding. On an unknown date, the patient experienced vaccine exposure during pregnancy. On an unknown date, the outcome of the threatened abortion, vaginal bleeding and vaccine exposure during pregnancy were unknown. The pregnancy was ongoing.   It was unknown if the reporter considered the threatened abortion and vaginal bleeding to be related to Menveo and Bexsero.  Additional details were reported as follows: The patient received Menveo vaccine and Bexsero vaccine. On 27th August 2020, patient's  had a positive pregnancy test result.  The patient did not know she was pregnant at the time she got the vaccines. On 2nd September 2020, the patient went to the emergency room with vaginal bleeding and miscarriage symptoms. On 9th September 2020, the patient had a follow up visit with her obstetrician gynecologisy doctor and reported that all was fine with the pregnancy. The emergency room visit was required.
Starting approx. 16 hrs post-injection, I developed whole body joint & muscle aches, chills, sweats, loss of appetite. This resulted in my being bed or couch ridden for 3 days. Ibuprofen helped some. Remained afebrile throughout.
After receiving vaccination, patient was reported to have fainted, with a potential seizure, and fallen over resulting in injury to head and laceration to forehead. Pharmacist was notified in which patient was immediately placed in laying position with elevation to her head and support to neck. Patient reported nausea, confusion, attempted to vomit without success. Patient was able to report name when prompted. 911 was called, fire service and ambulatory service arrived for further assessment. Patient was deemed safe without necessity of going to emergency room.
-shingles activation near chest. Never had a shingles episode before, had chickenpox as a child
Onset of pressure at the back of the head shortly after receiving the shot. No other neurologic symptoms.   No CP, SOB, weakness. She thought her BP might be high. Symptoms resolved before second normal BP below was recorded. Initial BP 154/95, Pulse 70, O2 sat 97%. Second BP 5 minutes later as 132/85.
A report was received from a health care professional, concerning a 15 year old male vaccinee who was inadvertently administered last years Fluvirin formulation on 10/24/02. No adverse effect was reported. There was insufficient information to determine the reporter's causality assessment. Ref: PJP2002-00652, PJP200200651 and PJP200200650.
Pt. stated that she didn't feel well after vaccines were given.  Nurse had her lay her head down on desk.  She then said she was feeling worse, she did lose consousness briefly(10-15sec.) Her father helped move her to the floor, where cold pack was placed on her neck and feet were elevated.  When she was able, she also was given a juice drink.
pretty significant joint pain; headache; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (pretty significant joint pain) and HEADACHE (headache) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced ARTHRALGIA (pretty significant joint pain) and HEADACHE (headache). On 02-Feb-2021, ARTHRALGIA (pretty significant joint pain) had resolved. At the time of the report, HEADACHE (headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event,s a causal relationship cannot be excluded.  Nevertheless, for the event headache the concomitant drug adderall could be a confounder.
No other AE or PQC reported; vaccine administered after temperature excursion.; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 01-OCT-2021, the patient was vaccinated with an improper stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U015689 and expiration date 18-MAY-2023, 0.5 milliliter for prophylaxis (strength, route, frequency and anatomical location were unknown).      The administered dose of the vaccine was stored with a temperature of 25.9 degrees Fahrenheit, with a time frame of 1 hour and 30 minutes. There was no previous temperature excursion. No adverse event reported (product storage error and no adverse event).
Patient reported numbness on right side of face down cheek to mouth and tongue - checked in with patient one hour later, numbness spread to arm and back. Numbness came and went. BENADRYL helps.
Patient became unconscious and had 2 seizures post receiving the MCV, Hep A and Varicella. Was transferred to the Hosp. via ambulance then on to another Hosp. 6-9-14 Mom via hospital took child to another hospital but was released at 4 AM. Neurologist said it was from having a Varicella at 4 y/o then one on 6/3/14. However child did not have Varicella at 4 y/o. Mom requesting cardiology referral from PCP as child's father had a similar issue at a young age.
Information was received on 19-APR-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. It is complained and alleged that the patient was inoculated with a dose of ZOSTAVAX vaccine on or about 30-JUN-2016 at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 02-JUL-2016, the patient was treated at a medical center for a painful rash that was diagnosed as shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Additional information has been requested.
Received 1st dose of Moderna vaccine lot number 041L20A; A spontaneous report was received from a consumer who was also a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and received 1st dose of Moderna vaccine lot number 041L20A.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number: 041L20A) intramuscularly for prophylaxis of COVID-19 infection. The lot number was later recalled.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The event, received 1st dose of Moderna vaccine lot number 041L20A, was resolved on unknown date.; Reporter's Comments: This report refers to a case of a female consumer of an unknown age who received a first dose Moderna's COVID 19 vaccine (Lot # 041L20A), that had been recalled, for prophylaxis of COVID-19 infection. No relevant medical history or con meds were provided. There were no reported AEs associated with this case of female consumer who received a recalled Moderna's COVID-19 vaccine.
This spontaneous report as received from a Registered Nurse refers to a 26 year old female patient. She had no pertinent medical history, no drug reactions or allergies and she was not taking concomitant medications. On 01-JUL-2015, the patient was vaccinated with a dose of M-M-R II (0.5 ml, subcutaneous, lot number reported as: K008815 and expiry: 19-JUN-2016) and with a dose of ENGERIX-B (dose, route, lot # not provided). Approximately on 15-JUL-2015 (reported as "2 weeks later"), the patient experienced "rash all over her body". Due to this event, she visited the Emergency Room on 17-JUL-2015. However, she was not admitted and was discharged on the same day. The patient recovered from rash all over her body on an unspecified date in 2015. Relatedness between the event and suspect vaccines was not specified. Additional information has been requested.
arm hurts; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (arm hurts) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurts). The patient was treated with NAPROXEN for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    No treatment information was reported.   Concomitant medications were not provided by the reporter.
Giant blister inside of her mouth; Flu symptoms; This case was reported by a pharmacist via call center representative and described the occurrence of blistering of mouth in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th February 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced blistering of mouth and flu symptoms. On an unknown date, the outcome of the blistering of mouth and flu symptoms were unknown.   It was unknown if the reporter considered the blistering of mouth and flu symptoms to be related to Shingrix.  Additional details were reported as follows: The patient after receiving the first dose of Shingrix experienced flu symptoms and had a giant blister inside of her mouth. The reporter consented to follow up. No vaccines data.
Dry throat; Headaches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DRY THROAT (Dry throat), HEADACHE (Headaches) and FATIGUE (Fatigue) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced DRY THROAT (Dry throat), HEADACHE (Headaches) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, DRY THROAT (Dry throat), HEADACHE (Headaches) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Covid; Never received second dose of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Covid) and PRODUCT DOSE OMISSION ISSUE (Never received second dose of the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid) and PRODUCT DOSE OMISSION ISSUE (Never received second dose of the vaccine). At the time of the report, COVID-19 (Covid) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Never received second dose of the vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not Applicable.  Treatment information was not provided.  Pharmacist want to know if they need to restart the vaccination series.
Pt. has always had mild anxiety  but on 4 March, he woke up with severe anxiety and went into his first panic attack that lasted weeks until we were able to get him into see a psychiatrist and prescribed prozac (40 mg) and seroquel (50 mg/XR).  he receives these daily now.   Specialist still are unsure of his diagnosis.  He no longer takes lexapro as we thought he may have been having "boxed" symptoms from that.  His other symptoms have been involuntary body movements, unable to catch breath during attacks and resembles seizures, visual hallucinations (color blobs and sometimes large scary bugs), lack of energy (i.e. cannot play for long periods of time), can not handle extreme heat and will collapse if outside for 5 minutes.
Approximately two days after my flu shot, I started having trouble lifting my right arm.  It got progressively worse, with a lot of pain and I was unable to move it normally or perform normal activities.  I have had acupuncture, taken antiinflammatories, seen my doctor twice and had a cortisone shot and physical therapy and massage.
Plus or minus 3 hours later shortness of breath, eyes burning with mucous, bottom lip numb, nose congestion, general aches. Patient had taken ZYRTEC already (takes daily).
Swollen throat, restricted breathing, shortness of breath, nausea, low grade fever, elevated heart rate